ContrastConnect has released a new guide on best practices for managing adverse reactions to contrast media.
-- The new guide was released as part of ContrastConnect’s educational resources for outpatient imaging facilities that provide contrast-enhanced CT and MRI scans as part of their services. In the guide, the company covers types of contrast reactions and proper documentation protocols that safeguard facilities from legal liabilities and protect patient safety.
For more information, please visit https://www.contrast-connect.com/blog-post/ct-contrast-reaction-management-documentation-best-practices
While contrast agents are generally safe and well-tolerated, allergic reactions can occur and require immediate attention. According to ContrastConnect, symptoms can escalate from mild to life-threatening, with the most severe reactions occurring within the first 20 minutes after administration. As a result, supervising physicians must be available at all times to direct trained staff to ensure there is no delay between symptom onset and interventions.
According to ContrastConnect’s guide, contrast reactions may be immediate or delayed, occurring within one hour of administration or up to seven days later, respectively. Symptoms may be mild, moderate, or severe, with each requiring different approaches: mild reactions are non-progressive and typically do not need intervention beyond monitoring, while moderate reactions may require medical treatment but are not life-threatening. Severe reactions occur much more rarely, but they may necessitate anaphylaxis protocols, including IV access, oxygen, and emergency response systems, to stabilize the patient.
ContrastConnect also notes that documentation is a necessary step for every contrast-enhanced imaging procedure, regardless of whether there is a reaction or not. The company’s guide says that this should begin before contrast administration and must include patient identifiers, baseline information, the exact name of the contrast agent, and premedication protocols; in the event of a reaction, onset time, symptom progression, treatment provided, and patient response should also be documented in great detail on the patient’s electronic health report.
Once the patient has recovered, staff should note their observation period, symptom resolution, vital signs, and discharge instructions; moderate and severe reactions may require referrals to immunologists after discharging, and this should be recorded as well.
Any omitted information, timestamp inconsistencies, or missing follow-up details can increase the risk of reaction recurrence and expose the facility to liability in the event of future contrast reactions, making thorough documentation a key component of patient safety.
More information is available at https://www.contrast-connect.com/
Contact Info:
Name: Dor Shoshan
Email: Send Email
Organization: ContrastConnect
Address: Las vegas, Las Vegas, NV 89109, United States
Website: https://www.contrast-connect.com/
Source: PressCable
Release ID: 89187530
In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.
